The regenerative potential of angiotensin AT 2 receptor in cardiac repair

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 3, 2012, Pages 287-293

  Ludwig, Marion ^a   Steinhoff, Gustav ^a   Li, Jun ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angiotensin; AT 2 receptor; Cardiac repair; Progenitor cell; Regeneration

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; CARDIOVASCULAR AGENT; CO 21; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CARDIAC REPAIR; CELL DIFFERENTIATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCLERODERMA; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REGENERATION; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 84863236837     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-108     Document Type: Article

References (61)

1. + cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells, 27(10): 2488-2497. doi:10.1002/ stem.171.
2. Bahlmann, F.H., de Groot, K., Mueller, O., Hertel, B., Haller, H., and Fliser, D. 2005. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension, 45(4): 526-529. doi:10.1161/01.HYP.0000159191. 98140.89.
3. Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susini, C., Strosberg, A.D., and Nahmias, C. 1997. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem. J. 325(2): 449-454.
4. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6): 763-776. doi:10.1016/S0092-8674(03)00687-1.
5. Bosnyak, S., Welungoda, I.K., Hallberg, A., Alterman, M., Widdop, R.E., and Jones, E.S. 2010. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 159(3): 709-716. doi:10.1111/j.1476-5381. 2009.00575.x.
6. Brinckmann, M., Kaschina, E., Altarche-Xifró, W., Curato, C., Timm, M., Grzesiak, A., et al. 2009. Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells. J. Mol. Cell. Cardiol. 47(1): 66-75. doi:10.1016/j.yjmcc.2009.03. 014.
7. Busche, S., Gallinat, S., Bohle, R., Reinecke, A., Seebeck, J., Franke, F., et al. 2000. Expression of angiotensin AT1 and AT2 receptors in adult rat cardiomyocytes after myocardial infarction: a single-cell reverse transcriptase-polymerase chain reaction study. Am. J. Pathol. 157(2): 605-611. doi:10.1016/S0002-9440(10)64571-3.
8. Côté, F., Laflamme, L., Payet, M., and Gallo-Payet, N. 1998. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr. Res. 24(3-4): 403-407. doi:10.3109/07435809809032622.
9. Côté, F., Do, T.H., Laflamme, L., Gallo, J.-M., and Gallo-Payet, N. 1999. Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J. Biol. Chem. 274(44): 31686-31692. doi:10. 1074/jbc.274.44.31686.
10. Curato, C., Slavic, S., Dong, J., Skorska, A., Altarche-Xifró, W., Miteva, K., et al. 2010. Identification of noncytotoxic and IL-10 producing CD8+AT2R+ T cell population in response to ischemic heart injury. J. Immunol. 185(10): 6286-6293. doi:10.4049/ jimmunol.0903681.
11. Daviet, L., Lehtonen, J.Y.A., Hayashida, W., Dzau, V.J., and Horiuchi, M. 2001. Intracellular third loops in AT1 and AT2 receptors determine subtype specificity. Life Sci. 69(5): 509-516. doi:10.1016/S0024-3205(01)01144-4.
12. Dawn, B., Stein, A.B., Urbanek, K., Rota, M., Whang, B., Rastaldo, R., et al. 2005. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl. Acad. Sci. U.S.A. 102(10): 3766-3771. doi:10.1073/pnas.0405957102.
13. de Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W., and Unger, T. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52(3): 415-472.
14. Fazel, S., Cimini, M., Chen, L., Li, S., Angoulvant, D., Fedak, P., et al. 2006. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116(7): 1865-1877. doi:10.1172/JCI27019.
15. Frangogiannis, N.G. 2006. The mechanistic basis of infarct healing. Antioxid. Redox Signal. 8(11-12): 1907-1939. doi:10.1089/ars. 2006.8.1907.
16. Funke-Kaiser, H., Reinemund, J., Steckelings, U.M., and Unger, T. 2010. Adapter proteins and promoter regulation of the angiotensin AT2 receptor - implications for cardiac pathophysiology. J. Renin Angiotensin Aldosterone Syst. 11(1): 7-17. doi:10.1177/1470320309343652.
17. Gelosa, P., Pignieri, A., Fändriks, L., de Gasparo, M., Hallberg, A., Banfi, C., et al. 2009. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J. Hypertens. 27(12): 2444-2451. doi:10.1097/HJH. 0b013e3283311ba1.
18. Gohlke, P., Pees, C., and Unger, T. 1998. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension, 31(1): 349-355.
19. Hayashida, W., Horiuchi, M., and Dzau, V.J. 1996. Intracellular third loop domain of angiotensin II type-2 receptor. Role in mediating signal transduction and cellular function. J. Biol. Chem. 271(36): 21985-21992. doi:10.1074/jbc.271.36.21985.
20. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., et al. 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109(13): 1615-1622. doi:10.1161/01.CIR.0000124476.32871.E3.
21. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., and Kobilka, B.K. 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature, 377(6551): 744-747. doi:10.1038/377744a0.
22. Huang, X.C., Richards, E.M., and Sumners, C. 1996. Mitogenactivated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J. Biol. Chem. 271(26): 15635-15641. doi:10.1074/jbc.271.26.15635.
23. Ichiki, T., Labosky, P.A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., et al. 1995. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature, 377(6551): 748-750. doi:10.1038/377748a0.
24. Iwanami, J., Mogi, M., Li, J.-M., Tsukuda, K., Min, L.-J., Sakata, A., et al. 2008. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke, 39(9): 2554-2559. doi:10.1161/STROKEAHA.107.513275.
25. Kaschina, E., Grzesiak, A., Li, J., Foryst-Ludwig, A., Timm, M., Rompe, F., et al. 2008. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the reninangiotensin system in myocardial infarction? Circulation, 118 (24): 2523-2532. doi:10.1161/CIRCULATIONAHA.108.784868.
26. Kissel, C.K., Lehmann, R., Assmus, B., Aicher, A., Honold, J., Fischer-Rasokat, U., et al. 2007. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J. Am. Coll. Cardiol. 49(24): 2341-2349. doi:10.1016/j.jacc.2007.01.095.
27. Koninckx, R., Daniëls, A., Windmolders, S., Carlotti, F., Mees, U., Steels, P., et al. 2011. Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study. Cell. Mol. Life Sci. 68(12): 2141-2156. doi:10.1007/s00018-010-0560-y.PMID:20972814.
28. Krause, M.W., Fonseca, V.A., and Shah, S.V. 2011. Combination inhibition of the renin-angiotensin system: is more better? Kidney Int. 80(3): 245-255. doi:10.1038/ki.2011.142.
29. Krikov, M., Thone-Reineke, C., Müller, S., Villringer, A., and Unger, T. 2008. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens. 26(3): 544-552. doi:10.1097/HJH. 0b013e3282f2dac9.
30. Lenkei, Z., Palkovits, M., Corvol, P., and Llorens-Cortès, C. 1997. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18(4): 383-439. doi:10.1006/frne. 1997.0155.
31. Li, J., Culman, J., Hörtnagl, H., Zhao, Y., Gerova, N., Timm, M., et al. 2005. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19(6): 617-619.
32. Liu, Y.H., Yang, X.P., Sharov, V.G., Nass, O., Sabbah, H.N., Peterson, E., and Carretero, O.A. 1997. Effects of angiotensinconverting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99(8): 1926-1935. doi:10.1172/JCI119360.
33. McMullen, N.M., and Pasumarthi, K.B.S. 2007. Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies? Can. J. Physiol. Pharmacol. 85(1): 1-15. doi:10.1139/Y06-105.
34. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., et al. 2004. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95(9): 911-921. doi:10.1161/01.RES.0000147315.71699.51.
35. Miura, S.-i., and Karnik, S.S. 2000. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J. 19(15): 4026-4035. doi:10.1093/emboj/19.15.4026.
36. Miura, S.-I., Karnik, S.S., and Saku, K. 2005. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J. Biol. Chem. 280(18): 18237-18244. doi:10.1074/ jbc.M500639200.
37. Miyamoto, S., Kawaguchi, N., Ellison, G.M., Matsuoka, R., Shin'oka, T., and Kurosawa, H. 2010. Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts. Stem Cells Dev. 19(1): 105-116. doi:10.1089/scd.2009.0041.
38. Miyata, N., Park, F., Li, X.F., and Cowley, A.W., Jr. 1999. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am. J. Physiol. 277(3): F437-F446.
39. Mogi, M., Li, J.-M., Iwanami, J., Min, L.-J., Tsukuda, K., Iwai, M., and Horiuchi, M. 2006. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension, 48(1): 141-148. doi:10.1161/01.HYP.0000229648.67883.f9.
40. Murry, C.E., Soonpaa, M.H., Reinecke, H., Nakajima, H., Nakajima, H.O., Rubart, M., et al. 2004. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428(6983): 664-668. doi:10.1038/nature02446.
41. Nygren, J.M., Jovinge, S., Breitbach, M., Sawen, P., Roll, W., Hescheler, J., et al. 2004. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5): 494-501. doi:10.1038/nm1040.
42. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829): 701-705. doi:10.1038/35070587.
43. Paul, M., Poyan Mehr, A., and Kreutz, R. 2006. Physiology of local renin-angiotensin systems. Physiol. Rev. 86(3): 747-803. doi:10. 1152/physrev.00036.2005.
44. Pfeffer, M.A., McMurray, J.J., Velazquez, E.J., Rouleau, J.-L., Køber, L., Maggioni, A.P., et al. Valsartan in Acute Myocardial Infarction Trial Investigators. 2003. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysunction, or both. N. Engl. J. Med. 349(20): 1893-1906. doi:10. 1056/NEJMoa032292.
45. Reinecke, K., Lucius, R., Reinecke, A., Rickert, U., Herdegen, T., and Unger, T. 2003. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kB. FASEB J. 17(14): 2094-2096.
46. Rompe, F., Artuc, M., Hallberg, A., Alterman, M., Stroder, K., Thone-Reineke, C., et al. 2010. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappa B. Hypertension, 55(4): 924-931. doi:10.1161/HYPERTENSIONAHA.109. 147843.
47. Santi, F., Stroder, K., Rompe, F., Wieland, A., Artuc, M., and Thone-Reineke, C. 2009. Anti-inflammatory and anti-fibrotic effect of angiotensin AT2 receptors stimulation or AT1 receptors blockade in scleroderma. Arthritis Rheum. 60(Suppl. 10): 1066. [abstract.]
48. Senbonmatsu, T., Saito, T., Landon, E.J., Watanabe, O., Price, E., Jr, Roberts, R.L., et al. 2003. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 22(24): 6471-6482. doi:10.1093/emboj/cdg637.
49. Simpson, S.A., Tait, J.F., and Bush, I.E. 1952. Secretion of a saltretaining hormone by the mammalian adrenal cortex. Lancet, 2 (6727): 226-228. doi:10.1016/S0140-6736(52)91551-1.
50. Solomon, S.D., Skali, H., Anavekar, N.S., Bourgoun, M., Barvik, S., Ghali, J.K., et al. 2005. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation, 111(25): 3411-3419. doi:10.1161/CIRCULATIONAHA.104.508093.
51. Stamm, C., Westphal, B., Kleine, H.-D., Petzsch, M., Kittner, C., Klinge, H., et al. 2003. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet, 361(9351): 45-46. doi:10.1016/S0140-6736(03)12110-1.
52. Steckelings, U.M., Rompe, F., Kaschina, E., Namsolleck, P., Grzesiak, A., Funke-Kaiser, H., et al. 2010a. The past, present and future of angiotensin II type 2 receptor stimulation. J. Renin Angiotensin Aldosterone Syst. 11(1): 67-73. doi:10.1177/1470320309347791.
53. Steckelings, U.M., Widdop, R.E., Paulis, L., and Unger, T. 2010b. The angiotensin AT2 receptor in left ventricular hypertrophy. J. Hypertens. 28(Suppl 1): S50-S55. doi:10.1097/01.hjh. 0000388495.66330.63.
54. Tallini, Y.N., Greene, K.S., Craven, M., Spealman, A., Breitbach, M., Smith, J., et al. 2009. C-kit expression identifies cardiovascular precursors in the neonatal heart. Proc. Natl. Acad. Sci. U.S.A. 106 (6): 1808-1813. doi:10.1073/pnas.0808920106.
55. Urbanek, K., Quaini, F., Tasca, G., Torella, D., Castaldo, C., Nadal-Ginard, B., et al. 2003. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S.A. 100(18): 10440-10445. doi:10.1073/pnas.1832855100.
56. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., et al. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89(1): e1-e7. doi:10.1161/ hh1301.093953.
57. Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A.K., Wu, X., et al. 2004. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J. Med. Chem. 47(24): 5995-6008. doi:10.1021/jm049715t.
58. Wang, Z.-Q., Moore, A.F., Ozono, R., Siragy, H.M., and Carey, R.M. 1998. Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension, 32(1): 78-83.
59. Whitebread, S., Mele, M., Kamber, B., and de Gasparo, M. 1989. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163(1): 284-291. doi:10.1016/0006-291X(89)92133-5.
60. Widdop, R.E., Jones, E.S., Hannan, R.E., and Gaspari, T.A. 2003. Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol. 140(5): 809-824. doi:10.1038/sj.bjp.0705448.
61. Xaymardan, M., Cimini, M., Fazel, S., Weisel, R.D., Lu, W.-Y., Martin, U., et al. 2009. C-Kit function is necessary for in vitro myogenic differentiation of bone marrow hematopoietic cells. Stem Cells, 27(8): 1911-1920. doi:10.1002/stem.106.